Skip to main content
Erschienen in: European Journal of Pediatrics 2/2015

01.02.2015 | Original Article

Brain imaging findings and social/emotional problems in Israeli children with neurofibromatosis type 1

verfasst von: Rony Cohen, Tamar Steinberg, Liora Kornreich, Sharon Aharoni, Ayelet Halevy, Avinoam Shuper

Erschienen in: European Journal of Pediatrics | Ausgabe 2/2015

Einloggen, um Zugang zu erhalten

Abstract

A potential association between brain MRI findings and social/emotional difficulties in children with neurofibromatosis type 1 (NF1) was examined. Twenty-eight children with NF1 filled in the Strengths and Difficulties Questionnaire (SDQ), and possible associations between their responses and findings in their brain MRI were sought. T2 bright foci were identified in MRI scans of 24 patients (85 %). There were no associations between the presence of the bright foci in any specific brain region and any of the SDQ scores for the emotional/behavioral measures. Male patients had significantly abnormal SDQ scores and peer problems. Patients with abnormal SDQ scores were younger than those with normal SDQ scores (mean 13.2 years vs 14.3 years, respectively; p = 0.23). A comparison of the scores obtained in ours and in another group of 11 children with NF1 yielded a significant difference between the groups. Conclusion: We believe that the lack of correlation between the MRI findings and the social/emotional parameters of the SDQ is another demonstration of the marked clinical variability characteristic of NF1.
Literatur
1.
Zurück zum Zitat [No authors listed] (1988) National Institute of Health Consensus Development Conference: Neurofibromatosis Conference Statement. Arch Neurol 45:575–578 [No authors listed] (1988) National Institute of Health Consensus Development Conference: Neurofibromatosis Conference Statement. Arch Neurol 45:575–578
2.
Zurück zum Zitat Alkindy A, Chuzhanova N, Kini U, Cooper DN, Upadhyaya M (2012) Genotype- phenotype associations in neurofibromatosis type 1 (NF1): an increased risk of tumor complications in patients with NF1 splice-site mutations? Hum Genom 6(12):2–7 Alkindy A, Chuzhanova N, Kini U, Cooper DN, Upadhyaya M (2012) Genotype- phenotype associations in neurofibromatosis type 1 (NF1): an increased risk of tumor complications in patients with NF1 splice-site mutations? Hum Genom 6(12):2–7
3.
Zurück zum Zitat Barton B, North K (2007) The self concept of children and adolescents with neurofibromatosis type 1. Child Care Health Dev 33:401–408PubMedCrossRef Barton B, North K (2007) The self concept of children and adolescents with neurofibromatosis type 1. Child Care Health Dev 33:401–408PubMedCrossRef
4.
Zurück zum Zitat Chabernaud C, Sirinelli D, Barbier C, Cottier JP, Sembely C, Giraudeau B, Deseille-Turlotte G, Lorette G, Barthez MA, Castelnau P (2009) Thalamo-striatal T2-weighted hyperintensities (unidentified bright objects) correlate with cognitive impairments in neurofibromatosis type 1 during childhood. Dev Neuropsychol 34:736–748PubMedCrossRef Chabernaud C, Sirinelli D, Barbier C, Cottier JP, Sembely C, Giraudeau B, Deseille-Turlotte G, Lorette G, Barthez MA, Castelnau P (2009) Thalamo-striatal T2-weighted hyperintensities (unidentified bright objects) correlate with cognitive impairments in neurofibromatosis type 1 during childhood. Dev Neuropsychol 34:736–748PubMedCrossRef
5.
Zurück zum Zitat Cutting LE, Koth CW, Burnette CP, Abrams MT, Kaufmann WE, Denckla MB (2000) Relationship of cognitive functioning, whole brain volumes and T2 weight hyperintensities in neurofibromatosis 1. J Child Neurol 15:157–160PubMedCrossRef Cutting LE, Koth CW, Burnette CP, Abrams MT, Kaufmann WE, Denckla MB (2000) Relationship of cognitive functioning, whole brain volumes and T2 weight hyperintensities in neurofibromatosis 1. J Child Neurol 15:157–160PubMedCrossRef
6.
Zurück zum Zitat Denckla MB, Hofman K, Mazzocco MM, Melhem E, Reiss AL, Bryan RN, Harris EL, Lee J, Cox CS, Schuerholz LJ (1996) Relationship between T2-weighted hyperintensities (unidentified bright objects) and lower IQs in children with neurofibromatosis-1. Am J Med Genet 67:98–102PubMedCrossRef Denckla MB, Hofman K, Mazzocco MM, Melhem E, Reiss AL, Bryan RN, Harris EL, Lee J, Cox CS, Schuerholz LJ (1996) Relationship between T2-weighted hyperintensities (unidentified bright objects) and lower IQs in children with neurofibromatosis-1. Am J Med Genet 67:98–102PubMedCrossRef
7.
Zurück zum Zitat Diggs-Andrews KA, Brown JA, Gianino SM, Rubin JB, Wozniak DF, Gutmann DH (2013) Sex is a major determinant of neuronal dysfunction in neurofibromatosis type 1. Ann Neurol [Epub ahead of print] Diggs-Andrews KA, Brown JA, Gianino SM, Rubin JB, Wozniak DF, Gutmann DH (2013) Sex is a major determinant of neuronal dysfunction in neurofibromatosis type 1. Ann Neurol [Epub ahead of print]
8.
Zurück zum Zitat Ferner RE, Chaudhuri R, Bingham J, Cox T, Huges RAC (1993) MRI in neurofibromatosis 1. The nature and evolution of increased intensity T2 weighted lesions and their relationship to intellectual impairment. J Neurol Neurosurg Psychiatry 56:492–495PubMedCentralPubMedCrossRef Ferner RE, Chaudhuri R, Bingham J, Cox T, Huges RAC (1993) MRI in neurofibromatosis 1. The nature and evolution of increased intensity T2 weighted lesions and their relationship to intellectual impairment. J Neurol Neurosurg Psychiatry 56:492–495PubMedCentralPubMedCrossRef
9.
Zurück zum Zitat Garg S, Lehtonen A, Huson SM, Emsley R, Trump D, Evans DG, Green J (2013) Autism and other psychiatric comorbidity in neurofibromatosis type 1: evidence from a population-based study. Dev Med Child Neurol 55:139–145PubMedCrossRef Garg S, Lehtonen A, Huson SM, Emsley R, Trump D, Evans DG, Green J (2013) Autism and other psychiatric comorbidity in neurofibromatosis type 1: evidence from a population-based study. Dev Med Child Neurol 55:139–145PubMedCrossRef
10.
Zurück zum Zitat Gill DS, Hyman SL, Steinberg A, North KN (2006) Age related findings on MRI in neurofibromatosis type 1. Pediatr Radiol 36:1048–1056PubMedCrossRef Gill DS, Hyman SL, Steinberg A, North KN (2006) Age related findings on MRI in neurofibromatosis type 1. Pediatr Radiol 36:1048–1056PubMedCrossRef
11.
Zurück zum Zitat Goh WHS, Khong P-l, Leung CS, Wong VCN (2004) T2-weighted hyperintensities (unidentified bright objects) in children with neurofibromatosis 1: their impact on cognitive function. J Child Neurol 19:853–858PubMed Goh WHS, Khong P-l, Leung CS, Wong VCN (2004) T2-weighted hyperintensities (unidentified bright objects) in children with neurofibromatosis 1: their impact on cognitive function. J Child Neurol 19:853–858PubMed
12.
Zurück zum Zitat Hyman SL, Gill DS, Shores EA, Steinberg A, North KN (2007) T2 hyperintensities in children with neurofibromatosis type 1 and their relationship to cognitive functioning. J Neurol Neurosurg Psychiatry 78:1088–1091PubMedCentralPubMedCrossRef Hyman SL, Gill DS, Shores EA, Steinberg A, North KN (2007) T2 hyperintensities in children with neurofibromatosis type 1 and their relationship to cognitive functioning. J Neurol Neurosurg Psychiatry 78:1088–1091PubMedCentralPubMedCrossRef
13.
Zurück zum Zitat Jentarra GM, Rice SG, Olfers S, Rajan C, Saffen DM, Narayanan V (2012) Skewed allele-specific expression of the NF1 gene in normal subjects: a possible mechanism for phenotypic variability in neurofibromatosis type 1. J Child Neurol 27:695–702PubMedCrossRef Jentarra GM, Rice SG, Olfers S, Rajan C, Saffen DM, Narayanan V (2012) Skewed allele-specific expression of the NF1 gene in normal subjects: a possible mechanism for phenotypic variability in neurofibromatosis type 1. J Child Neurol 27:695–702PubMedCrossRef
14.
Zurück zum Zitat Ko JM, Sohn YB, Jeong SY, Kim HJ, Messiaen LM (2013) Mutation spectrum of NF1 and clinical characteristics in 78 Korean patients with neurofibromatosis type 1. Pediatr Neurol 48:447–453PubMedCrossRef Ko JM, Sohn YB, Jeong SY, Kim HJ, Messiaen LM (2013) Mutation spectrum of NF1 and clinical characteristics in 78 Korean patients with neurofibromatosis type 1. Pediatr Neurol 48:447–453PubMedCrossRef
15.
Zurück zum Zitat Lehtonen A, Howie E, Trump D, Huson SM (2013) Behaviour in children with neurofibromatosis type 1: executive function, attention, emotion and social competence. Dev Med Child Neurol 55:111–125PubMedCrossRef Lehtonen A, Howie E, Trump D, Huson SM (2013) Behaviour in children with neurofibromatosis type 1: executive function, attention, emotion and social competence. Dev Med Child Neurol 55:111–125PubMedCrossRef
16.
Zurück zum Zitat Levenson D (2014) Gender plays role in predicting neuronal dysfunction for patients with neurofibromatosis 1: girls more likely to require treatment for visual decline caused by NF1-related brain tumors. Am J Med Genet A 164A(5):VIII–IX Levenson D (2014) Gender plays role in predicting neuronal dysfunction for patients with neurofibromatosis 1: girls more likely to require treatment for visual decline caused by NF1-related brain tumors. Am J Med Genet A 164A(5):VIII–IX
17.
Zurück zum Zitat Mansbach-Kleinfeld I, Levine SZ, Apter A, Levine SZ, Ponizovsky AM (2010) A population-based psychometric validation study of the Strengths and Difficulties Questionnaire—Hebrew version. Front Psychiatry 1:151PubMedCentralPubMedCrossRef Mansbach-Kleinfeld I, Levine SZ, Apter A, Levine SZ, Ponizovsky AM (2010) A population-based psychometric validation study of the Strengths and Difficulties Questionnaire—Hebrew version. Front Psychiatry 1:151PubMedCentralPubMedCrossRef
18.
Zurück zum Zitat Moore BD III, Slopis JM, Schomer D, Jackson EF, Levy BM (1996) Neuropsychological significance of areas of high signal intensity on brain MRIs of children with neurofibromatosis. Neurology 46:1660–1668PubMedCrossRef Moore BD III, Slopis JM, Schomer D, Jackson EF, Levy BM (1996) Neuropsychological significance of areas of high signal intensity on brain MRIs of children with neurofibromatosis. Neurology 46:1660–1668PubMedCrossRef
19.
Zurück zum Zitat Pasmant E, Vidaud M, Vidaud D, Wolkenstein P (2012) Neurofibromatosis type 1: from genotype to phenotype. J Med Genet 49:483–489PubMedCrossRef Pasmant E, Vidaud M, Vidaud D, Wolkenstein P (2012) Neurofibromatosis type 1: from genotype to phenotype. J Med Genet 49:483–489PubMedCrossRef
20.
Zurück zum Zitat Payne JM, Moharir MD, Webster R, North KN (2010) Brain structure and function in neurofibromatosis type1: current concepts and future directions. J Neurol Neurosurg Psychiatry 81:304–309PubMedCrossRef Payne JM, Moharir MD, Webster R, North KN (2010) Brain structure and function in neurofibromatosis type1: current concepts and future directions. J Neurol Neurosurg Psychiatry 81:304–309PubMedCrossRef
21.
Zurück zum Zitat Pride NA, Korgaonkar MS, Barton B, Payne JM, Vucic S, North KN (2013) The genetic and neuroanatomical basis of social dysfunction: lessons from neurofibromatosis type 1. Hum Brain Mapp [Epub ahead of print] Pride NA, Korgaonkar MS, Barton B, Payne JM, Vucic S, North KN (2013) The genetic and neuroanatomical basis of social dysfunction: lessons from neurofibromatosis type 1. Hum Brain Mapp [Epub ahead of print]
22.
Zurück zum Zitat Van Roy B, Groholt B, Heyerdahl S, Clench-Aas J (2006) Self-reported strengths and difficulties in a large Norwegian population 10–19 years. Eur Child Adolesc Psychiatry 15:189–198PubMedCrossRef Van Roy B, Groholt B, Heyerdahl S, Clench-Aas J (2006) Self-reported strengths and difficulties in a large Norwegian population 10–19 years. Eur Child Adolesc Psychiatry 15:189–198PubMedCrossRef
Metadaten
Titel
Brain imaging findings and social/emotional problems in Israeli children with neurofibromatosis type 1
verfasst von
Rony Cohen
Tamar Steinberg
Liora Kornreich
Sharon Aharoni
Ayelet Halevy
Avinoam Shuper
Publikationsdatum
01.02.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Pediatrics / Ausgabe 2/2015
Print ISSN: 0340-6199
Elektronische ISSN: 1432-1076
DOI
https://doi.org/10.1007/s00431-014-2366-7

Weitere Artikel der Ausgabe 2/2015

European Journal of Pediatrics 2/2015 Zur Ausgabe

Neuer Typ-1-Diabetes bei Kindern am Wochenende eher übersehen

23.04.2024 Typ-1-Diabetes Nachrichten

Wenn Kinder an Werktagen zum Arzt gehen, werden neu auftretender Typ-1-Diabetes und diabetische Ketoazidosen häufiger erkannt als bei Arztbesuchen an Wochenenden oder Feiertagen.

Neue Studienergebnisse zur Myopiekontrolle mit Atropin

22.04.2024 Fehlsichtigkeit Nachrichten

Augentropfen mit niedrig dosiertem Atropin können helfen, das Fortschreiten einer Kurzsichtigkeit bei Kindern zumindest zu verlangsamen, wie die Ergebnisse einer aktuellen Studie mit verschiedenen Dosierungen zeigen.

Spinale Muskelatrophie: Neugeborenen-Screening lohnt sich

18.04.2024 Spinale Muskelatrophien Nachrichten

Seit 2021 ist die Untersuchung auf spinale Muskelatrophie Teil des Neugeborenen-Screenings in Deutschland. Eine Studie liefert weitere Evidenz für den Nutzen der Maßnahme.

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

18.04.2024 Pädiatrische Notfallmedizin Nachrichten

Im Choosing-Wisely-Programm, das für die deutsche Initiative „Klug entscheiden“ Pate gestanden hat, sind erstmals Empfehlungen zum Umgang mit Notfällen von Kindern erschienen. Fünf Dinge gilt es demnach zu vermeiden.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.